Functional Genomics meets neurodegenerative disorders Part I: Transcriptomic and proteomic technology

[1]  C. Adessi,et al.  Improvement of the solubilization of proteins in two‐dimensional electrophoresis with immobilized pH gradients , 2006, Electrophoresis.

[2]  R. Nitsch,et al.  Impaired spatial reference memory and increased exploratory behavior in P301L tau transgenic mice , 2006, Genes, brain, and behavior.

[3]  R. Ravid,et al.  Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice* , 2005, Journal of Biological Chemistry.

[4]  Ilana S. Hairston,et al.  Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice , 2005, Cell.

[5]  Jason A. Papin,et al.  Reconstruction of cellular signalling networks and analysis of their properties , 2005, Nature Reviews Molecular Cell Biology.

[6]  Fujian Zhang,et al.  Mitochondrial Proteomic Analysis of a Cell Line Model of Familial Amyotrophic Lateral Sclerosis* , 2004, Molecular & Cellular Proteomics.

[7]  K. Parker,et al.  Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.

[8]  K. Markides,et al.  Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography‐Fourier transform ion cyclotron resonance mass spectrometry , 2004, Proteomics.

[9]  P. Day,et al.  Reference genes identified in SH-SY5Y cells using custom-made gene arrays with validation by quantitative polymerase chain reaction. , 2004, Analytical biochemistry.

[10]  David Martin,et al.  GOToolBox: functional analysis of gene datasets based on Gene Ontology , 2004, Genome Biology.

[11]  J. Götz,et al.  Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models , 2004, International Journal of Developmental Neuroscience.

[12]  Eliot Marshall,et al.  Getting the Noise Out of Gene Arrays , 2004, Science.

[13]  E. Lander,et al.  Finishing the euchromatic sequence of the human genome , 2004 .

[14]  Ruedi Aebersold,et al.  Analysis of α-Synuclein-associated Proteins by Quantitative Proteomics*[boxs] , 2004, Journal of Biological Chemistry.

[15]  M. Mann,et al.  The abc's (and xyz's) of peptide sequencing , 2004, Nature Reviews Molecular Cell Biology.

[16]  R. Nitsch,et al.  The impact of genetic background on neurodegeneration and behavior in seizured mice , 2004, Genes, brain, and behavior.

[17]  Feng Chen,et al.  Posttranslational modifications of tau--role in human tauopathies and modeling in transgenic animals. , 2004, Current drug targets.

[18]  J. Streffer,et al.  Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy , 2004, Molecular Psychiatry.

[19]  S. Lipton,et al.  Molecular pathways to neurodegeneration , 2004, Nature Medicine.

[20]  L. Bruijn,et al.  Unraveling the mechanisms involved in motor neuron degeneration in ALS. , 2004, Annual review of neuroscience.

[21]  Jochen Klucken,et al.  Hsp70 Reduces α-Synuclein Aggregation and Toxicity* , 2004, Journal of Biological Chemistry.

[22]  Joanna M. Sasin,et al.  Protein Tyrosine Phosphatases in the Human Genome , 2004, Cell.

[23]  D. Goodlett,et al.  Proteomic approach to studying parkinson’s disease , 2004, Molecular Neurobiology.

[24]  John Q. Trojanowski,et al.  Single-Cell Gene Expression Analysis: Implications for Neurodegenerative and Neuropsychiatric Disorders , 2004, Neurochemical Research.

[25]  D. Lewis,et al.  Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction , 2004, Psychopharmacology.

[26]  C. Weissmann,et al.  The role of PrP in health and disease. , 2004, Current molecular medicine.

[27]  E. Rogaev,et al.  Role for glyoxalase I in Alzheimer's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Bennett,et al.  Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. , 2004, Archives of neurology.

[29]  Joachim Klose,et al.  Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice* , 2004, Journal of Biological Chemistry.

[30]  J Günter Grossmann,et al.  Dimer destabilization in superoxide dismutase may result in disease-causing properties: structures of motor neuron disease mutants. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Nitsch,et al.  Accelerated extinction of conditioned taste aversion in P301L tau transgenic mice , 2004, Neurobiology of Disease.

[32]  Allan I. Levey,et al.  Oxidative Modifications and Down-regulation of Ubiquitin Carboxyl-terminal Hydrolase L1 Associated with Idiopathic Parkinson's and Alzheimer's Diseases* , 2004, Journal of Biological Chemistry.

[33]  Marquis P Vawter,et al.  Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree , 2004, Schizophrenia Research.

[34]  G. Stephanopoulos,et al.  Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. , 2004, Physiological genomics.

[35]  Gregory A Petsko,et al.  Live and let diet , 2003, Genome Biology.

[36]  D. Borchelt,et al.  Environmental Enrichment Exacerbates Amyloid Plaque Formation in a Transgenic Mouse Model of Alzheimer Disease , 2003, Journal of neuropathology and experimental neurology.

[37]  Bryan L Roth,et al.  Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons* , 2003, Journal of Biological Chemistry.

[38]  R. Nitsch,et al.  β-Amyloid Induces Paired Helical Filament-like Tau Filaments in Tissue Culture* , 2003, Journal of Biological Chemistry.

[39]  R. Lempicki,et al.  Evaluation of gene expression measurements from commercial microarray platforms. , 2003, Nucleic acids research.

[40]  Á. Pascual,et al.  Induction of tyrosine kinase receptor b by retinoic acid allows brain-derived neurotrophic factor-induced amyloid precursor protein gene expression in human sh-sy5y neuroblastoma cells , 2003, Neuroscience.

[41]  Douglas A. Hosack,et al.  Identifying biological themes within lists of genes with EASE , 2003, Genome Biology.

[42]  A. Delacourte,et al.  Mitotic-like Tau Phosphorylation by p25-Cdk5 Kinase Complex* , 2003, Journal of Biological Chemistry.

[43]  C. Messier.  Diabetes, Alzheimer's disease and apolipoprotein genotype , 2003, Experimental Gerontology.

[44]  D. Butterfield,et al.  Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration , 2003, Journal of neurochemistry.

[45]  H. Shibasaki,et al.  Presenilin 1 mediates retinoic acid‐induced differentiation of SH‐SY5Y cells through facilitation of Wnt signaling , 2003, Journal of neuroscience research.

[46]  Robert Tonge,et al.  Evaluation of saturation labelling two‐dimensional difference gel electrophoresis fluorescent dyes , 2003, Proteomics.

[47]  Wayne F. Patton,et al.  Global quantitative phosphoprotein analysis using Multiplexed Proteomics technology , 2003, Proteomics.

[48]  M. Laakso,et al.  Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease , 2003, The European journal of neuroscience.

[49]  J. Loring,et al.  Selectively Reduced Expression of Synaptic Plasticity-Related Genes in Amyloid Precursor Protein + Presenilin-1 Transgenic Mice , 2003, The Journal of Neuroscience.

[50]  Visith Thongboonkerd,et al.  Proteomic identification of nitrated proteins in Alzheimer's disease brain , 2003, Journal of neurochemistry.

[51]  Thomas Huber,et al.  Phosphoregulators: protein kinases and protein phosphatases of mouse. , 2003, Genome research.

[52]  J. Collinge,et al.  Molecular and clinical classification of human prion disease. , 2003, British medical bulletin.

[53]  M. Beal.  Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.

[54]  J. Inman,et al.  A new strategy to amplify degraded RNA from small tissue samples for microarray studies. , 2003, Nucleic acids research.

[55]  E. Bézard,et al.  Microarray analysis of nonhuman primates: validation of experimental models in neurological disorders , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[56]  Hongqing Guo,et al.  Single-Cell Microarray Analysis in Hippocampus CA1: Demonstration and Validation of Cellular Heterogeneity , 2003, The Journal of Neuroscience.

[57]  H. D. Morris,et al.  Prolonged exercise induces angiogenesis and increases cerebral blood volume in primary motor cortex of the rat , 2003, Neuroscience.

[58]  S. Pelech,et al.  Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord , 2003, Journal of neurochemistry.

[59]  Y. Dudai,et al.  The amygdalar circuit that acquires taste aversion memory differs from the circuit that extinguishes it , 2003, The European journal of neuroscience.

[60]  A. Singleton,et al.  Genes and parkinsonism , 2003, The Lancet Neurology.

[61]  Subramanian Rajagopalan,et al.  Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo A Novel Therapy for Parkinson's Disease , 2003, Neuron.

[62]  Eden Martin,et al.  Genomic convergence: identifying candidate genes for Parkinson's disease by combining serial analysis of gene expression and genetic linkage. , 2003, Human molecular genetics.

[63]  F. Kamme,et al.  Global gene expression analysis of single cells. , 2003, Current opinion in drug discovery & development.

[64]  Zhon-Yin Zhang,et al.  An overview of the protein tyrosine phosphatase superfamily. , 2003, Current topics in medicinal chemistry.

[65]  F. Menzies,et al.  Analysis of the Cytosolic Proteome in a Cell Culture Model of Familial Amyotrophic Lateral Sclerosis Reveals Alterations to the Proteasome, Antioxidant Defenses, and Nitric Oxide Synthetic Pathways* , 2003, The Journal of Biological Chemistry.

[66]  A. Young.  Huntingtin in health and disease. , 2003, The Journal of clinical investigation.

[67]  K. Blennow,et al.  Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins. , 2002, Brain research. Molecular brain research.

[68]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[69]  D. Alkon,et al.  Memory-specific temporal profiles of gene expression in the hippocampus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Patrizia Rizzu,et al.  Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.

[71]  G. Sobue,et al.  Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords – screening by molecular indexing and subsequent cDNA microarray analysis , 2002, FEBS letters.

[72]  M. Ball,et al.  Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down‐regulation and up‐regulation of apoptotic and pro‐inflammatory signaling , 2002, Journal of neuroscience research.

[73]  E. Mufson,et al.  Gene Expression Profiles of Cholinergic Nucleus Basalis Neurons in Alzheimer's Disease , 2002, Neurochemical Research.

[74]  I. Alafuzoff,et al.  Proteomic analysis of protein oxidation in Alzheimer's disease brain , 2002, Electrophoresis.

[75]  Jürgen Götz,et al.  Glial cells under physiologic and pathologic conditions. , 2002, Archives of neurology.

[76]  D. Butterfield,et al.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase‐related protein 2, α‐enolase and heat shock cognate 71 , 2002, Journal of neurochemistry.

[77]  M. Strong.  Biochemical markers: Summary , 2002, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[78]  S. Shimohama,et al.  Proteomic Profiling and Neurodegeneration in Alzheimer's Disease , 2002, Neurochemical Research.

[79]  D. Butterfield,et al.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. , 2002, Free radical biology & medicine.

[80]  A. Delacourte,et al.  Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer’s disease , 2002, Neurology.

[81]  Ronald J Moore,et al.  Global analysis of the Deinococcus radiodurans proteome by using accurate mass tags , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[82]  Tony Wyss-Coray,et al.  Inflammation in Neurodegenerative Disease—A Double-Edged Sword , 2002, Neuron.

[83]  Dieter Stoll,et al.  Protein microarray technology. , 2002, Drug discovery today.

[84]  Kelvin H. Lee,et al.  Studies of potential cerebrospinal fluid molecular markers for Alzheimer's disease , 2002, Electrophoresis.

[85]  S. Shimohama,et al.  Analysis of the Proteomic Profiling of Brain Tissue in Alzheimer's Disease , 2002, Disease markers.

[86]  J. Trojanowski,et al.  The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases. , 2002, Free radical biology & medicine.

[87]  Youmin Wang,et al.  Conditions to ensure competitive hybridization in two-color microarray: a theoretical and experimental analysis. , 2002, BioTechniques.

[88]  Wayne F. Patton,et al.  An improved formulation of SYPRO Ruby protein gel stain: Comparison with the original formulation and with a ruthenium II tris (bathophenanthroline disulfonate) formulation , 2002, Proteomics.

[89]  Kaj Blennow,et al.  Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients , 2002, Neuroreport.

[90]  Mary F. Lopez,et al.  Applied proteomics: mitochondrial proteins and effect on function. , 2002, Circulation research.

[91]  John R Yates,et al.  Analysis of quantitative proteomic data generated via multidimensional protein identification technology. , 2002, Analytical chemistry.

[92]  T. Haystead,et al.  Molecular Biologist's Guide to Proteomics , 2002, Microbiology and Molecular Biology Reviews.

[93]  B. Gerrits,et al.  Preparative two‐dimensional gel electrophoresis at alkaline pH using narrow range immobilized pH gradients , 2002, Proteomics.

[94]  B. Violand,et al.  Development of improved cell lysis, solubilization and imaging approaches for proteomic analyses , 2002, Proteomics.

[95]  T. Godfrey,et al.  Real‐time Quantitative Polymerase Chain Reaction: A Potential Tool for Genetic Analysis in Neuropathology , 2002, Brain pathology.

[96]  I. Everall,et al.  Rapid Tyrosine Phosphorylation of Neuronal Proteins Including Tau and Focal Adhesion Kinase in Response to Amyloid-β Peptide Exposure: Involvement of Src Family Protein Kinases , 2002, The Journal of Neuroscience.

[97]  G. Sobue,et al.  Differential expression of inflammation‐ and apoptosis‐related genes in spinal cords of a mutant SOD1 transgenic mouse 
model of familial amyotrophic lateral sclerosis , 2002, Journal of neurochemistry.

[98]  E. Lein,et al.  Transcriptional profiling reveals strict boundaries between hippocampal subregions , 2001, The Journal of comparative neurology.

[99]  Ruedi Aebersold,et al.  Advances in Proteome Analysis by Mass Spectrometry* , 2001, The Journal of Biological Chemistry.

[100]  H. Lipp,et al.  Conditioned taste aversion as a learning and memory paradigm , 2001, Behavioural Brain Research.

[101]  S. Grant,et al.  Proteomics in Neuroscience: From Protein to Network , 2001, The Journal of Neuroscience.

[102]  R. Faull,et al.  Proteomic analysis of the brain in Alzheimer’s disease: Molecular phenotype of a complex disease process , 2001, Proteomics.

[103]  J M Lee,et al.  A gene expression profile of Alzheimer's disease. , 2001, DNA and cell biology.

[104]  J. Yates,et al.  An automated multidimensional protein identification technology for shotgun proteomics. , 2001, Analytical chemistry.

[105]  F. Regnier,et al.  Fractionation of isotopically labeled peptides in quantitative proteomics. , 2001, Analytical chemistry.

[106]  M. A. Moseley,et al.  Current trends in differential expression proteomics: isotopically coded tags. , 2001, Trends in biotechnology.

[107]  G. Pasinetti,et al.  Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia , 2001, Journal of neuroscience research.

[108]  Piali Mukherjee,et al.  Gene expression profiling of the tau mutant (P301L) transgenic mouse brain , 2001, Neuroscience Letters.

[109]  R. Nitsch,et al.  Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.

[110]  J. Hardy,et al.  Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP , 2001, Science.

[111]  Cheng Li,et al.  Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application , 2001, Genome Biology.

[112]  R. Quirion,et al.  DNA microarrays in neuropsychopharmacology. , 2001, Trends in pharmacological sciences.

[113]  Jürgen Götz,et al.  Tau and transgenic animal models , 2001, Brain Research Reviews.

[114]  Roger E Bumgarner,et al.  Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. , 2001, Science.

[115]  M. Zirlinger,et al.  Amygdala-enriched genes identified by microarray technology are restricted to specific amygdaloid subnuclei , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[116]  J. Belleroche,et al.  Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. , 2001 .

[117]  J. Trojanowski,et al.  PP2A mRNA Expression Is Quantitatively Decreased in Alzheimer's Disease Hippocampus , 2001, Experimental Neurology.

[118]  D. Butterfield,et al.  Protein oxidation in the brain in Alzheimer's disease , 2001, Neuroscience.

[119]  J. Yates,et al.  Large-scale analysis of the yeast proteome by multidimensional protein identification technology , 2001, Nature Biotechnology.

[120]  Matthew Davison,et al.  Validation and development of fluorescence two‐dimensional differential gel electrophoresis proteomics technology , 2001, Proteomics.

[121]  A. Stensballe,et al.  Characterization of phosphoproteins from electrophoretic gels by nanoscale Fe(III) affinity chromatography with off‐line mass spectrometry analysis , 2001, Proteomics.

[122]  P. Brown,et al.  Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions , 2001, Genome Biology.

[123]  R. Nitsch,et al.  Tau Filament Formation in Transgenic Mice Expressing P301L Tau* , 2001, The Journal of Biological Chemistry.

[124]  D. Holtzman,et al.  Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. , 2000, The Journal of clinical investigation.

[125]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[126]  A. Freemont,et al.  Subtractive hybridization – genetic takeaways and the search for meaning , 2000, International journal of experimental pathology.

[127]  Jiasen Lu,et al.  Assessment of the sensitivity and specificity of oligonucleotide (50mer) microarrays. , 2000, Nucleic acids research.

[128]  L. Wodicka,et al.  Regional and strain-specific gene expression mapping in the adult mouse brain. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[129]  S. Gygi,et al.  Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[130]  J. Shabanowitz,et al.  Subfemtomole MS and MS/MS peptide sequence analysis using nano-HPLC micro-ESI fourier transform ion cyclotron resonance mass spectrometry. , 2000, Analytical chemistry.

[131]  T. Dawson,et al.  Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease , 2000, Neurobiology of Disease.

[132]  Wen-Lang Lin,et al.  Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein , 2000, Nature Genetics.

[133]  A. Görg,et al.  Towards higher resolution: Two‐dimensional Electrophoresis of Saccharomyces cerevisiae proteins using overlapping narrow immobilized pH gradients , 2000, Electrophoresis.

[134]  J. Trojanowski,et al.  Expression profile of transcripts in Alzheimer's disease tangle‐bearing CA1 neurons , 2000, Annals of neurology.

[135]  M. Mann,et al.  Proteomics to study genes and genomes , 2000, Nature.

[136]  A. Roses.  Pharmacogenetics and the practice of medicine , 2000, Nature.

[137]  P. Verhaert,et al.  Identification of two‐dimensionally separated human cerebrospinal fluid proteins by N‐terminal sequencing, matrix‐assisted laser desorption/ionization — mass spectrometry, nanoliquid chromatography‐electrospray ionization‐time of flight‐mass spectrometry, and tandem mass spectrometry , 2000, Electrophoresis.

[138]  J R Yates,et al.  Analysis of the microbial proteome. , 2000, Current opinion in microbiology.

[139]  G. Kroemer,et al.  Simplification of complex peptide mixtures for proteomic analysis: Reversible biotinylation of cysteinyl peptides , 2000, Electrophoresis.

[140]  A. Görg,et al.  The current state of two‐dimensional electrophoresis with immobilized pH gradients , 2000, Electrophoresis.

[141]  S. Weinberger,et al.  Recent advancements in surface‐enhanced laser desorption/ionization‐time of flight‐mass spectrometry , 2000, Electrophoresis.

[142]  Wayne F. Patton,et al.  Ultrasensitive fluorescence protein detection in isoelectric focusing gels using a ruthenium metal chelate stain , 2000, Electrophoresis.

[143]  Wayne F. Patton,et al.  Fluorescence detection of proteins in sodium dodecyl sulfate‐polyacrylamide gels using environmentally benign, nonfixative, saline solution , 2000, Electrophoresis.

[144]  J. Rowley,et al.  Generation of longer cDNA fragments from serial analysis of gene expression tags for gene identification. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[145]  H. Braak,et al.  Filamentous Tau Pathology in Nerve Cells, Astrocytes, and Oligodendrocytes of Aged Baboons , 2000, Journal of neuropathology and experimental neurology.

[146]  J. F. Atkins,et al.  Programmed ribosomal frameshifting: much ado about knotting! , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[147]  D. N. Perkins,et al.  Probability‐based protein identification by searching sequence databases using mass spectrometry data , 1999, Electrophoresis.

[148]  M. Guazzelli,et al.  Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits. , 1999, Journal of neuropathology and experimental neurology.

[149]  W. Kamphorst,et al.  Phenotypic variation in hereditary frontotemporal dementia with tau mutations , 1999, Annals of neurology.

[150]  S. Gygi,et al.  Quantitative analysis of complex protein mixtures using isotope-coded affinity tags , 1999, Nature Biotechnology.

[151]  P. Lansbury,et al.  Amyloid diseases: abnormal protein aggregation in neurodegeneration. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[152]  G. Anderson,et al.  High-mass-measurement accuracy and 100% sequence coverage of enzymatically digested bovine serum albumin from an ESI-FTICR mass spectrum. , 1999, Analytical chemistry.

[153]  A. Brookes.  The essence of SNPs. , 1999, Gene.

[154]  J. Yates,et al.  Direct analysis of protein complexes using mass spectrometry , 1999, Nature Biotechnology.

[155]  G. Anderson,et al.  Probing proteomes using capillary isoelectric focusing-electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. , 1999, Analytical chemistry.

[156]  G. Schellenberg,et al.  A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L) , 1999, Brain : a journal of neurology.

[157]  J. Weingarten,et al.  Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques , 1999, Annals of neurology.

[158]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[159]  J Q Trojanowski,et al.  Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. , 1998, The American journal of pathology.

[160]  R. Reddel,et al.  Differential display of mRNA , 1998, Molecular biotechnology.

[161]  A. Schapira,et al.  Mitochondrial dysfunction in neurodegenerative disorders. , 1998, Biochimica et biophysica acta.

[162]  Q. Zhu,et al.  Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[163]  A Klug,et al.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[164]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[165]  G. Schellenberg,et al.  Tau is a candidate gene for chromosome 17 frontotemporal dementia , 1998, Annals of neurology.

[166]  J. Kong,et al.  Massive Mitochondrial Degeneration in Motor Neurons Triggers the Onset of Amyotrophic Lateral Sclerosis in Mice Expressing a Mutant SOD1 , 1998, The Journal of Neuroscience.

[167]  B. Chait,et al.  Protein indentification using mass spectrometric information , 1998, Electrophoresis.

[168]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[169]  A. Verkman,et al.  Evidence for phosphorylation of serine 753 in CFTR using a novel metal‐ion affinity resin and matrix‐assisted laser desorption mass spectrometry , 1997, Protein science : a publication of the Protein Society.

[170]  J. Morrison,et al.  Life and death of neurons in the aging brain. , 1997, Science.

[171]  J Collinge,et al.  Human prion diseases and bovine spongiform encephalopathy (BSE). , 1997, Human molecular genetics.

[172]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[173]  R. Anderegg,et al.  Comprehensive on-line LC/LC/MS of proteins. , 1997, Analytical chemistry.

[174]  K Johansson,et al.  Heritability for Alzheimer's disease: the study of dementia in Swedish twins. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[175]  C. Olanow,et al.  Oxidative stress and the pathogenesis of Parkinson's disease , 1996, Neurology.

[176]  J. Slade,et al.  Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene: pathological and immunocytochemical changes , 1996, Acta Neuropathologica.

[177]  M. Terzano,et al.  Precocious loss of physiological sleep in a case of Creutzfeldt Jakob disease: a serial polygraphic study. , 1995, Sleep.

[178]  Y. Agid,et al.  Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias , 1995, Nature.

[179]  D. Butterfield,et al.  Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation , 1995, Journal of neurochemistry.

[180]  K. Kinzler,et al.  Serial Analysis of Gene Expression , 1995, Science.

[181]  D. Borchelt,et al.  An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria , 1995, Neuron.

[182]  M. Wilm,et al.  Error-tolerant identification of peptides in sequence databases by peptide sequence tags. , 1994, Analytical chemistry.

[183]  M. Gurney,et al.  Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. , 1994, The American journal of pathology.

[184]  C. Marsden,et al.  Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease , 1994, Annals of neurology.

[185]  M. Carson,et al.  ALS, SOD and peroxynitrite , 1993, Nature.

[186]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[187]  B. Snow,et al.  Rapidly progressive autosomal dominant parkinsonism and dementia with pallido‐ponto‐nigral degeneration , 1992, Annals of neurology.

[188]  A. Pardee,et al.  Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. , 1992, Science.

[189]  P. Mcgeer,et al.  Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. , 1992, The American journal of pathology.

[190]  W. Greenough,et al.  Exercise and the Brain: Angiogenesis in the Adult Rat Cerebellum after Vigorous Physical Activity and Motor Skill Learning , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[191]  Ronald C. Beavis,et al.  Matrix-assisted laser desorption/ionization mass spectrometry of biopolymers. , 1991, Analytical chemistry.

[192]  W. Greenough,et al.  Learning causes synaptogenesis, whereas motor activity causes angiogenesis, in cerebellar cortex of adult rats. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[193]  L. Thal,et al.  The Lewy body variant of Alzheimer's disease , 1990, Neurology.

[194]  M. Mann,et al.  Electrospray ionization for mass spectrometry of large biomolecules. , 1989, Science.

[195]  E. Mufson,et al.  Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: A quantitative analysis across subregions of the basal forebrain , 1989, Experimental Neurology.

[196]  M. Karas,et al.  Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. , 1988, Analytical chemistry.

[197]  K. Biemann.  Contributions of mass spectrometry to peptide and protein structure. , 1988, Biomedical & environmental mass spectrometry.

[198]  P. Castaigne,et al.  The epidemiology of Creutzfeldt‐Jakob disease , 1987, Neurology.

[199]  J. Porath,et al.  Isolation of phosphoproteins by immobilized metal (Fe3+) affinity chromatography. , 1986, Analytical biochemistry.

[200]  G. P. Smith,et al.  Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. , 1985, Science.

[201]  P. Roepstorff,et al.  Proposal for a common nomenclature for sequence ions in mass spectra of peptides. , 1984, Biomedical mass spectrometry.

[202]  J. Coyle,et al.  Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. , 1982, Science.

[203]  P. Davies,et al.  SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE , 1976, The Lancet.

[204]  J. Klose.  Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues , 1975, Humangenetik.

[205]  P. O’Farrell.  High resolution two-dimensional electrophoresis of proteins. , 1975, The Journal of biological chemistry.

[206]  F. Nicoletti,et al.  Beta-amyloid-activated cell cycle in SH-SY5Y neuroblastoma cells: correlation with the MAP kinase pathway. , 2004, Journal of Molecular Neuroscience.

[207]  P. Jenner,et al.  Oxidative stress in Parkinson's disease , 2003, Annals of neurology.

[208]  P. Carmeliet,et al.  VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death , 2003, Nature Genetics.

[209]  S. Pelech,et al.  Kinetworks protein kinase multiblot analysis. , 2003, Methods in molecular biology.

[210]  Jürgen Götz,et al.  Alzheimer's and Parkinson's disease--overlapping or synergistic pathologies? , 2002, Trends in molecular medicine.

[211]  K. Markides,et al.  Peptide mapping of proteins in human body fluids using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. , 2002, Mass spectrometry reviews.

[212]  D. Rodriguez,et al.  Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease , 2001, Nature Genetics.

[213]  G. Lubec,et al.  Aberrant expression of dihydropyrimidinase related proteins-2,-3 and -4 in fetal Down syndrome brain. , 2001, Journal of neural transmission. Supplementum.

[214]  G. Pasinetti,et al.  From cDNA microarrays to high-throughput proteomics. Implications in the search for preventive initiatives to slow the clinical progression of Alzheimer's disease dementia. , 2001, Restorative neurology and neuroscience.

[215]  A. Ryo,et al.  A modified serial analysis of gene expression that generates longer sequence tags by nonpalindromic cohesive linker ligation. , 2000, Analytical biochemistry.

[216]  D. Schmid,et al.  FTICR-mass spectrometry for high-resolution analysis in combinatorial chemistry. , 2000, Biotechnology and bioengineering.

[217]  J. Pevsner,et al.  High throughput analysis of gene expression in the human brain , 2000, Journal of Neuroscience Research.

[218]  M. Graeber,et al.  Role of Mitochondria in Parkinson Disease , 1999, Biological chemistry.

[219]  W. Tatton,et al.  Etiology and pathogenesis of Parkinson's disease. , 1999, Annual review of neuroscience.

[220]  J. Seilhamer,et al.  A comparison of selected mRNA and protein abundances in human liver , 1997, Electrophoresis.

[221]  H. Sive,et al.  Subtractive cloning: past, present, and future. , 1997, Annual review of biochemistry.

[222]  W R Markesbery,et al.  Oxidative stress hypothesis in Alzheimer's disease. , 1997, Free radical biology & medicine.

[223]  G. Corthals,et al.  Prefractionation of protein samples prior to two‐dimensional electrophoresis , 1997, Electrophoresis.

[224]  Banks Jf,et al.  Electrospray ionization mass spectrometry. , 1996 .

[225]  G Brady,et al.  Construction of cDNA libraries from single cells. , 1993, Methods in enzymology.

[226]  R. Wyatt,et al.  Cerebrospinal fluid protein variations in common to Alzheimer's disease and schizophrenia. , 1992, Applied and theoretical electrophoresis : the official journal of the International Electrophoresis Society.

[227]  G. V. Van Hoesen,et al.  The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. , 1991, Cerebral cortex.